TWi, Takeda Settle Generic Dexilant Patent Suit
TWi Pharmaceuticals Inc. said Monday that it has reached a settlement with Takeda Pharmaceutical Co. Ltd. and its subsidiaries that resolves and dismisses all outstanding patent litigation related to Takeda's acid...To view the full article, register now.
Already a subscriber? Click here to view full article